UPDATED: New York State Conditionally Approves Natera to Offer Expanded Panorama Test | GenomeWeb

The story has been updated to clarify that the New York State approval includes the regular Panorama panel and 22q11.2 deletion syndrome.

NEW YORK (GenomeWeb) – Prenatal testing firm Natera today said that it has received conditional approval from New York State to offer the expanded Panorama non-invasive prenatal test to residents in the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.